(Q34310561)

English

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

microRNA expression

0 references

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

object named as

Thomas H Carter

14

0 references

Klaus H Metzeler

object named as

Klaus H Metzeler

10

0 references

Richard A. Larson

object named as

Richard A Larson

20

0 references

22

object named as

Guido Marcucci

1 reference

Europe PubMed Central

1 August 2017

Clara D. Bloomfield

23

object named as

Clara D Bloomfield

1 reference

Europe PubMed Central

1 August 2017

Krzysztof Mrózek

5

object named as

Krzysztof Mrózek

1 reference

Europe PubMed Central

1 August 2017

2

object named as

Kati Maharry

1 reference

Europe PubMed Central

1 August 2017

Michael A Caligiuri

21

object named as

Michael A Caligiuri

1 reference

Europe PubMed Central

1 August 2017

Jonathan E Kolitz

15

object named as

Jonathan E Kolitz

1 reference

Europe PubMed Central

1 August 2017

16

object named as

Meir Wetzler

1 reference

Europe PubMed Central

1 August 2017

Kelsi B Holland

7

object named as

Kelsi B Holland

1 reference

Europe PubMed Central

1 August 2017

Bayard L Powell

13

object named as

Bayard L Powell

1 reference

Europe PubMed Central

1 August 2017

4

object named as

Heiko Becker

1 reference

Europe PubMed Central

1 August 2017

6

object named as

Dean Margeson

1 reference

Europe PubMed Central

1 August 2017

Sebastian Schwind

9

object named as

Sebastian Schwind

1 reference

Europe PubMed Central

1 August 2017

author name string

Susan P Whitman

1

1 reference

Europe PubMed Central

1 August 2017

Michael D Radmacher

3

1 reference

Europe PubMed Central

1 August 2017

Yue-Zhong Wu

8

1 reference

Europe PubMed Central

1 August 2017

Jing Wen

11

1 reference

Europe PubMed Central

1 August 2017

Maria R Baer

12

1 reference

Europe PubMed Central

1 August 2017

Joseph O Moore

17

1 reference

Europe PubMed Central

1 August 2017

Richard M Stone

18

1 reference

Europe PubMed Central

1 August 2017

Andrew J Carroll

19

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

23 July 2010

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

116

1 reference

Europe PubMed Central

1 August 2017

3622-3626

1 reference

Europe PubMed Central

1 August 2017

18

1 reference

Europe PubMed Central

1 August 2017

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

WT1 peptide vaccination for the treatment of hematological malignancies: the present status and future direction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

MicroRNA expression in cytogenetically normal acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

6 July 2018

A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

28 October 2018

Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

28 October 2018

BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

28 October 2018

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981481

28 October 2018

An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/20656931

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/20656931

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2010-05-283648

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34310561&oldid=1984607723"